Journal profile · Virology
Influenza and Other Respiratory Viruses
ISSN 1750-2640 · eISSN 1750-2659 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Bimonthly
Influenza and Other Respiratory Viruses: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.86; fully open access; APC about USD 4,840; median 146 days to acceptance (87 articles, last 24 months); community-reported acceptance: easy; 162 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Influenza and Other Respiratory Viruses is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Influenza Virus Research Studies, Respiratory viral infections research and COVID-19 epidemiological studies, together about 56.9% of its articles. Its main subfields are Epidemiology and Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases — an independent scientific professional society — dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
From the journal's Aims & Scope
Research area (LetPub): Virology
Editor-in-chief Ian BarrPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United Kingdom 12, United States 9, Australia 7, Japan 3, Singapore 3 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Influenza Virus Research StudiesMedicine26.4%
- Respiratory viral infections researchMedicine25.6%
- COVID-19 epidemiological studiesMathematics4.9%
- Pneumonia and Respiratory InfectionsMedicine4.8%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.5%
- COVID-19 Clinical Research StudiesMedicine4.2%
- Data-Driven Disease SurveillanceMedicine3.1%
- SARS-CoV-2 detection and testingMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Virology | Zone 2 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Virology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.86LetPub ·
- Impact factor (publisher) 2025
- 3.9Publisher website ·
- CiteScore 2026-06
- 7.6LetPub ·
- CiteScore (publisher) 2025
- 7.6Publisher website ·
- SJR 2026-06
- 1.63LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 46LetPub ·
- h-index
- 96OpenAlex ·
- i10-index
- 1,149OpenAlex ·
- 2-year mean citedness
- 3.92OpenAlex ·
- Self-citation rate
- 5.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 122LetPub ·
- Articles per year (publisher) 2025
- 129Publisher website ·
- Downloads per year (publisher) 2025
- 484,457Publisher website ·
Articles by year OpenAlex count · 2,221 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 133 | 133 | 51 |
| 2025 | 162 | 162 | 460 |
| 2024 | 198 | 198 | 1,424 |
| 2023 | 157 | 157 | 1,585 |
| 2022 | 138 | 138 | 2,758 |
| 2021 | 119 | 119 | 2,715 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
146 daysMedian, submission to acceptance · P25–P75 96 days – 187 days
- Acceptance to online
- median 20 days (87 articles)
- Submission to online
- median 173 days
- Sample
- 87 articles with submission and acceptance dates (324 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher) 2025
- 21%Publisher website ·
- Submission to first decision 2025
- 14 daysPublisher website ·
- Submission to acceptance 2025
- 132 daysPublisher website ·
- Acceptance to publication 2025
- 24 daysPublisher website ·
- Submission to publication (journal-reported)
- about 39 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 4,840 / GBP 3,090 / EUR 3,750 | Yes | CC BY | |
| OpenAlex | USD 4,840 / EUR 3,750 / GBP 3,090 | — | — | |
| LetPub | USD 4,400 / GBP 2,810 / EUR 3,410 | Yes | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Optional
Article types accepted4, with length limits
- letter to the editoriii. Letter to the Editor Word limit: Should not normally exceed three typewritten pages.Length not stated
- original articlei: 10.1111/j.1463-1318.2007.01421.x ii. Original Article Word limit: 5,000 words maximum (including tables, figures, and references). Abstracmain text ≤ 5,000 words
- review articlei. Review Article Review articles, which must undergo peer review, will generally be commissioned, but non-commissioned reviews on timely subjects will be consi…Length not stated
- short communicationr will be published free of charge. iv. Short Communication Word limit: 1,500 words maximum. Abstract: A summary of up to 100 words should be fmain text ≤ 1,500 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Plagiarism, Preprints
- Authorship Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing Policy
Please review Wiley’s policy here. This journal expects and peer review data sharing.
Source ↗Publisher website ·- Publication ethics Publication Ethics
COPE member Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Single-blind or transparent peer review Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind or transparent peer reviewed, depending on the choice of the author. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Plagiarism
iThenticate CrossCheck plagiarism detection Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints Preprint your manuscript while it’s under review
Preprints accepted Model summary
Beginning in early 2020, Influenza and Other Respiratory Viruses is participating in a pilot of the under review service, Wiley’s new initiative to streamline the early sharing of research and open up the peer review process. Authors can now opt to preprint their manuscript during the submission process and showcase their work to the global research community as a preprint, before it is accepted o…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 1750-2640
- Electronic ISSN
- 1750-2659
- Latest issue on the website
- Volume 20, Issue 9 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Influenza and Other Respiratory Viruses
What CAS zone is Influenza and Other Respiratory Viruses in?
In the 2025 upgraded edition of the CAS Journal Ranking, Influenza and Other Respiratory Viruses is in Zone 3 of Medicine, and in Zone 2 of the minor category Virology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Influenza and Other Respiratory Viruses?
The latest impact factor listed by LetPub is 3.86; CiteScore 7.6, h-index 96.
How long does peer review take at Influenza and Other Respiratory Viruses?
Based on the dates recorded on 87 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 146 days (interquartile range 96–187 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 21% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Influenza and Other Respiratory Viruses?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: AMA; First submission: Free format: the journal's layout is not required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Influenza and Other Respiratory Viruses based?
Of the 43 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United Kingdom (12), United States (9) and Australia (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Influenza and Other Respiratory Viruses?
According to LetPub and DOAJ records, Influenza and Other Respiratory Viruses is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Influenza and Other Respiratory Viruses open access, and what is the APC?
Influenza and Other Respiratory Viruses is a fully open-access journal. APC about USD 4,840.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .